Please assess the completion status of the following clinical trial:

Trial Title: Use of Ziv Aflibercept in Different Retinal Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The study included treatment naive patients suffering from recently diagnosed active myopic subfoveal or juxtafoveal CNV less than 2 months documented by fundus fluorescein angiography (FFA)and optical coherence tomography (OCT ) , pathological myopia more than 6 D was included .~Exclusion Criteria:~* Previous intraocular surgery .~* Coincident retinal pathology as diabetic retinopathy, retinal vein occlusion .~* CNV due to other causes like age related macular degeneration ,angioid streaks,trauma and choroiditis.~* Extrafoveal myopic CNV .~* Patients received other lines of treatment for CNV like photodynamic therapy ,laser photocoagulation or intravitreal injection of triamcinolone or other anti VEGF(vascular endothelial growth factor) agents.~* Known glaucoma , clinical suspicion of glaucoma or IOP(intraocular pressure) more than 20 mmHg.~* Prior ocular inflammation.~* The presence of retinal degeneration.~* Patients who didnot complete 6 months of follow up

- Gender: ALL
- Minimum Age: 31 Years
- Maximum Age: 63 Years
- Healthy Volunteers: t

Study Arms:
- ziv aflibercept patients (Type: EXPERIMENTAL): 20 eyes of myopic CNV,20 eyes with resistant diabetic macular edema and 15 eyes with non ischaemic CRVO

Based on this trial design, predict the completion outcome and termination type (if applicable).